Main menu LEO Pharma R&D Therapeutic areas Medicines Social responsibility Careers Menu section Dermatology Thrombosis Other Pharmacovigilance Medical Information Medicines from LEO Pharma We help patients have healthy skin. Patients are the main concern of LEO Pharma . They are at the heart of our activity and we deploy all our know-how to meet their needs. This approach applies to R&D as well as to LEO Pharma employees . We need to make sure that everything we do meets the needs of patients and helps improve their quality of life. LEO Pharma's vision is to be a leading partner in dermatology, and to participate in improving the lives of patients. We provide effective therapies and solutions that allow patients to better manage their disease and live happier lives. To achieve this, we place great emphasis on research and careful listening to better understand the needs of people with skin problems. This knowledge allows us to innovate and bring them real benefit. We work with patients and associations to create an environment in which they are considered and are offered better access to care and solutions adapted to their needs. In accordance with Article L.5121-1-3 of the Public Health Code, hereinafter is the list of active ingredients of drugs for which LEO Pharma is responsible for placing on the market: bumetanide: Burinex ® tablets, Burinex ® solution for injection calcipotriol: Daivonex ® cream, Daivonex ® scalp solution *, Daivonex ® ointment * fusidic acid: Fucidin ® cream, Fucidin ® oral suspension sodium fusidate : Fucidin ® ointment, Fucidin ® film-coated tablet heparin sodium: Heparin LEO solution for injection * tinzaparin sodium: Innohep ® solution for injection potassium chloride: Kaleorid ® LP, prolonged-release tablet pivmecillinam hydrochloride: Selexid ® film-coated tablet alfacalcidol: Un-alfa® oral capsule, Un-alfa ® oral solution, Un-alfa® solution for injection calcipotriol / Betamethasone: Daivobet ® Ointment, Daivobet ® Gel, Xamiol ® gel ingenol mebutate: Picato ® gel * Products not sold in France Updated 07/22/15 Dermatology Dermatology Thrombosis Thrombosis Footer menu Home Link transparency Contact Sitemap Legal Notice Cookies policy LEO Pharma Headquarters 2 rue René Caudron F-78960 NEIGHBORS-LE-BRETONNEUX SAS with a capital of 9,000,000 Euros 572 208 122 RCS Versailles Phone +33 1 30 14 40 00 Fax +33 1 34 60 47 90